Key result
Complete revascularisation significantly reduced one-year mortality compared to incomplete revascularisation in both STEMI (5.3% vs. 13.8%) and NSTEMI (4.5% vs. 10.3%) patients after propensity score matching.
Why the study?
Does complete revascularisation reduce one-year mortality in patients with myocardial infarction and multivessel disease compared to incomplete revascularisation?
Observational (n=4,520)
Yes
Does complete revascularisation reduce one-year mortality in patients with myocardial infarction and multivessel disease compared to incomplete revascularisation?
Absolute Event Rate: 5.3% vs 13.8%
p-value: p=<0.001
Complete revascularization in patients with myocardial infarction and multivessel disease is associated with significantly lower one-year mortality compared to a culprit-only strategy.
No takes yet. Share an insight, caveat, or question.
Registry data link complete revascularisation to lower one-year mortality in multivessel MI; leaves open confirmation by randomized trials with functional assessment.
Quadri et al. (2017) conducted an observational in Myocardial infarction with multivessel disease (n=4,520). Complete revascularisation vs. Incomplete revascularisation (culprit lesion only) was evaluated on All-cause death at 1 year (STEMI matched cohort) (p=<0.001). Complete revascularisation significantly reduced one-year mortality compared to incomplete revascularisation in both STEMI (5.3% vs. 13.8%) and NSTEMI (4.5% vs. 10.3%) patients after propensity score matching.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: